More recently, Silva et al. [36] analyzed a large registry of more than 40.000 HCC patients and found that patients with elevated (200–1999 ng/mL) and highly elevated (≥2000 ng/mL) basal AFP levels had impaired OS, regardless of the HCC treatment plan. This evidence concerns the gene AFP and hepatocellular carcinoma.